glp 1 agonist medullary thyroid cancer Does Using GLP-1 Drugs, Like Zepbound or Wegovy, Increase Your Risk of Cancer? Exploring the Side Effects of
Description
AUTHOR CONTRIBUTIONS Conception or design: A.B.M.K.H., D.D
For example, the 2018 European Association for the Study of Diabetes (EASD) and American Diabetes Association consensus guidelines recommend a sodiumglucose cotransporter2 (SGLT2) inhibitor or a GLP1 RA with proven cardiovascular benefits for patients with clinical cardiovascular disease
The comparator group, defined as patients who did not initiate GLP-1RA therapy during the study period, was constructed by aligning nonusers to GLP-1RA users within a 1-week window of the initiation date to ensure temporal comparability of treatment assignment
J.BatterhamR
This is an important and evolving topic
